Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 202

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Smartphone apps for calculating insulin dose: a systematic assessment

Open access
Huckvale, Kit, Adomaviciute, Samanta, Prieto, José Tomás, Leow, Melvin Khee-Shing, Car, Josip·2015·BMC Medicine

Abstract

BACKGROUND: Medical apps are widely available, increasingly used by patients and clinicians, and are being actively promoted for use in routine care. However, there is little systematic evidence exploring possible risks associated with apps intended for patient use. Because self-medication errors are a recognized source of avoidable harm, apps that affect medication use, such as dose calculators, deserve particular scrutiny. We explored the accuracy and clinical suitability of apps for calculating medication doses, focusing on insulin calculators for patients with diabetes as a representative use for a prevalent long-term condition. METHODS: We performed a systematic assessment of all English-language rapid/short-acting insulin dose calculators available for iOS and Android. RESULTS: Searches identified 46 calculators that performed simple mathematical operations using planned carbohydrate intake and measured blood glucose. While 59% (n = 27/46) of apps included a clinical disclaimer, only 30% (n = 14/46) documented the calculation formula. 91% (n = 42/46) lacked numeric input validation, 59% (n = 27/46) allowed calculation when one or more values were missing, 48% (n = 22/46) used ambiguous terminology, 9% (n = 4/46) did not use adequate numeric precision and 4% (n = 2/46) did not store parameters faithfully. 67% (n = 31/46) of apps carried a risk of inappropriate output dose recommendation that either violated basic clinical assumptions (48%, n = 22/46) or did not match a stated formula (14%, n = 3/21) or correctly update in response to changing user inputs (37%, n = 17/46). Only one app, for iOS, was issue-free according to our criteria. No significant differences were observed in issue prevalence by payment model or platform. CONCLUSIONS: The majority of insulin dose calculator apps provide no protection against, and may actively contribute to, incorrect or inappropriate dose recommendations that put current users at risk of both catastrophic overdose and more subtle harms resulting from suboptimal glucose control. Healthcare professionals should exercise substantial caution in recommending unregulated dose calculators to patients and address app safety as part of self-management education. The prevalence of errors attributable to incorrect interpretation of medical principles underlines the importance of clinical input during app design. Systemic issues affecting the safety and suitability of higher-risk apps may require coordinated surveillance and action at national and international levels involving regulators, health agencies and app stores.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12916-015-0314-7

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 34

  1. Seabrook H, Stromer J, Shevkenek C, Bharwani A, de Grood J, Ghali W. Medical applications: a database and characterization of apps in Apple iOS and Android platforms. BMC Res Notes. 2014;7:573. · DOI
  2. Digitas Health. mBook 2013 Edition - Marketing Mobile Health. 2013. http://m.2013.digitashealth.com/Mbook2013_web.pdf .
  3. Commission E. Green paper on mobile health (“mHealth”). Brussels: European Commission; 2014.
  4. Cortez NG, Cohen IG, Kesselheim AS. FDA regulation of mobile health technologies. N Engl J Med. 2014;371:372–9. · DOI · Paper page
  5. Yang YT, Silverman RD. Mobile health applications: the patchwork of legal and liability issues suggests strategies to improve oversight. Health Aff (Millwood). 2014;33:222–7. · DOI
  6. England NHS. Five year forward view. UK: HM Government; 2014.
  7. McCartney M. How do we know whether medical apps work? BMJ. 2013;346:f1811. · DOI
  8. Chomutare T, Fernandez-Luque L, Årsand E, Hartvigsen G. Features of mobile diabetes applications: review of the literature and analysis of current applications compared against evidence-based guidelines. J Med Internet Res. 2011;13:e65. · DOI · Paper page
  9. Abroms LC, Lee Westmaas J, Bontemps-Jones J, Ramani R, Mellerson J. A content analysis of popular smartphone apps for smoking cessation. Am J Prev Med. 2013;45:732–6. · DOI · Paper page
  10. Huckvale K, Car M, Morrison C, Car J. Apps for asthma self-management: a systematic assessment of content and tools. BMC Med. 2012;10:144. · DOI · Paper page
  11. Schachter M. The epidemiology of medication errors: how many, how serious? Br J Clin Pharmacol. 2009;67:621–3. · doi:10.1111/j.1365-2125.2009.03418.x
  12. Gandhi TK, Weingart SN, Borus J, Seger AC, Peterson J, Burdick E, et al. Adverse drug events in ambulatory care. N Engl J Med. 2003;348:1556–64. · DOI · Paper page
  13. Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003;289:1107–16. · DOI · Paper page
  14. Lamont T, Cousins D, Hillson R, Bischler A, Terblanche M. Safer administration of insulin: summary of a safety report from the National Patient Safety Agency. UK: National Patient Safety Agency; 2010.
  15. Sears K, Scobie A, MacKinnon NJ. Patient-related risk factors for self-reported medication errors in hospital and community settings in 8 countries. Can Pharm J (Ott). 2012;145:88–93. · doi:10.3821/145.2.cpj88
  16. Bierbrier R, Lo V, Wu RC. Evaluation of the accuracy of smartphone medical calculation apps. J Med Internet Res. 2014;16:e32. · DOI
  17. American Diabetes Association. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2008;31:S61–78. · DOI
  18. Rees C. Recommendations for insulin dose calculator risk management. J Diabetes Sci Technol. 2014;8:142–9. · DOI
  19. DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ. 2002;325:746. · DOI · Paper page
  20. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86. · DOI · Paper page
  21. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53. · DOI · Paper page
  22. Shashaj B, Busetto E, Sulli N. Benefits of a bolus calculator in pre- and postprandial glycaemic control and meal flexibility of paediatric patients using continuous subcutaneous insulin infusion (CSII). Diabet Med. 2008;25:1036–42. · DOI
  23. Gross TM, Kayne D, King A, Rother C, Juth S. A bolus calculator is an effective means of controlling postprandial glycemia in patients on insulin pump therapy. Diabetes Technol Ther. 2003;5:365–9. · DOI
  24. Spiller HA, Borys DJ, Ryan ML, Sawyer TS, Wilson BL. Unintentional therapeutic errors involving insulin in the ambulatory setting reported to poison centers. Ann Pharmacother. 2011;45:17–22. · doi:10.1345/aph.1p517
  25. Beuhler MC, Spiller HA, Aleguas A. Demographics and outcome of unintentional insulin overdoses managed by three poison centers. Clin Toxicol (Phila). 2013;51:789–93. · DOI
  26. Claydon-Platt K, Manias E, Dunning T. Medication-related problems occurring in people with diabetes during an admission to an adult teaching hospital: a retrospective cohort study. Diabetes Res Clin Pract. 2012;97:223–30. · DOI
  27. Reason J. Human error: models and management. BMJ. 2000;320:768–70. · DOI · Paper page
  28. Bailey SC, Brega AG, Crutchfield TM, Elasy T, Herr H, Kaphingst K, et al. Update on health literacy and diabetes. Diabetes Educ. 2014;40:581–604. · DOI · Paper page
  29. Albrecht UV, von Jan U, Jungnickel T, Pramann O. App-synopsis - standard reporting for medical apps. Stud Health Technol Inform. 2013;192:1154.
  30. Lewis TL. A systematic self-certification model for mobile medical apps. J Med Internet Res. 2013;15:e89. · DOI
  31. U.S. Food and Drug Administration. Mobile medical applications - guidance for industry and food and drug administration staff. Rockville, MD, USA: U.S: Department of Health and Human Services; 2013.
  32. Eng DS, Lee JM. The promise and peril of mobile health applications for diabetes and endocrinology. Pediatr Diabetes. 2013;14:231–8. · DOI · Paper page
  33. Charani E, Castro-Sanchez E, Moore L, Holmes A. Do smartphone applications in healthcare require a governance and legal framework? It depends on the application! BMC Med. 2014;12:29. · DOI
  34. Hill J, Powell P. The national healthcare crisis: is eHealth a key solution? Bus Horiz. 2009;52:265–77. · DOI

Cited by

See all 202

Metadata

Authors
Huckvale, K., Adomaviciute, S., Prieto, J. T., Leow, M. K.-S., & Car, J.
Venue
BMC Medicine
Published
2015-05-06
Volume
13
Issue
1
Pages
106-106
ISSN
1741-7015 (ISSN-L)
OpenAlex
W1554470992
Cited by
202
References
6
FWCI
49.66
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Smartphone apps for calculating insulin dose: a systematic assessment. https://app.cochat.ai/papers/10.1186/s12916-015-0314-7
The paper
Huckvale, K., Adomaviciute, S., Prieto, J. T., Leow, M. K.-S., & Car, J. (2015). Smartphone apps for calculating insulin dose: a systematic assessment. BMC Medicine. https://doi.org/10.1186/s12916-015-0314-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.